Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharosAI provides a secure ecosystem that unites large-scale multimodal cancer datasets with advanced AI models. The platform accelerates the development of next-generation diagnostics and therapies by making rich patient data accessible for analysis while maintaining strict governance. It aims to democratize access to high-quality oncology data for researchers, clinicians, pharma/biotech companies, and developers—enabling earlier diagnosis, more accurate predictions of disease progression/therapy response, and improved patient outcomes. No direct clinical results as it is an enabling technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharosAI.